Immunogenicity of reduced antigen content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing …

F Zepp, P Habermehl, M Knuf, W Mannhardt-Laakman… - Vaccine, 2007 - Elsevier
Three hundred and nineteen adolescents aged 10–12 years who had been previously
vaccinated with five doses of acellular pertussis-containing vaccines received single doses …

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

C Sirivichayakul, P Chanthavanich… - Human vaccines & …, 2017 - Taylor & Francis
ABSTRACT Background: An acellular Pertussis (aP) vaccine containing recombinant
genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and …

Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation

CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - Taylor & Francis
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …

A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2 …

S Sricharoenchai, C Sirivichayakul… - The Lancet Infectious …, 2018 - thelancet.com
Background Increasing evidence shows that protection induced by acellular pertussis
vaccines is short-lived, requiring repeated booster vaccination to control pertussis disease …

Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): results of two randomized …

WM Weston, LR Friedland, X Wu, B Howe - Vaccine, 2012 - Elsevier
BACKGROUND: Pertussis can cause significant morbidity in elderly patients, who can also
transmit this disease to infants and young children. There is little data available on the use of …

Waning protection after fifth dose of acellular pertussis vaccine in children

NP Klein, J Bartlett, A Rowhani-Rahbar… - … England Journal of …, 2012 - Mass Medical Soc
Background In the United States, children receive five doses of diphtheria, tetanus, and
acellular pertussis (DTaP) vaccine before 7 years of age. The duration of protection after five …

[HTML][HTML] Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial

F Martinón-Torres, SA Halperin, T Nolan, B Tapiéro… - Vaccine, 2021 - Elsevier
Background Transplacentally transferred antibodies induced by maternal pertussis
vaccination interfere with infant immune responses to pertussis primary vaccination. We …

Pertussis epidemiology and vaccination in the United States

TA Clark - 2012 - stacks.cdc.gov
CITE Title: Cost-effectiveness of pertussis vaccine substitution for tetanus booster in
prevention of pertussis in adults 65 years and older Personal Author (s): Acosta, Anna M …

US Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005–2007

S Chang, PM O'Connor, BA Slade, EJ Woo - Vaccine, 2013 - Elsevier
BACKGROUND: Pre-licensure clinical trials for two US licensed tetanus toxoid, reduced
diphtheria toxoid and acellular pertussis (Tdap) vaccines did not reveal any major safety …

[HTML][HTML] On the role of different age groups and pertussis vaccines during the 2012 outbreak in Wisconsin

E Goldstein, CJ Worby, M Lipsitch - Open Forum Infectious …, 2018 - academic.oup.com
Background There is limited information on the roles of different age groups in propagating
pertussis outbreaks, and on the impact of vaccination on pertussis transmission in the …